CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
Cell · 2026-03 · 189 (5) · 1555-1572.e23
DOI: 10.1016/j.cell.2025.12.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-03. Verfasst von Yinghua Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese A…. Hauptthemen laut MEDLINE: Tumor Microenvironment, T-Lymphocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Chinese Academy of Sciences, National Natural Science Foundation of China, National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
The tumor microenvironment (TME) poses a major barrier to effective immunotherapy, yet high-throughput perturbation-mapping approaches to dissect TME spatial complexity and its contextual immune modulators remain lacking. Here, we introduce CRISPR-laser-captured microdissection (LCM) integration mapping of the tumor-immune microenvironment (CLIM-TIME), a scalable platform that integrates CRISPR screening with LCM of metastatic tumors for transcriptomic, deconvolution, and immunofluorescence analyses. CLIM-TIME enables spatially resolved mapping of how tumor suppressor gene (TSG) loss reshapes the TME and modulates immune responses. We identified seven distinct TME subtypes, revealing that DNA repair and Polycomb repressive complex (PRC) TSG loss is linked to immune-infiltrated TMEs sensitive to T cell therapy. In contrast, knockouts of TSGs in the Hippo pathway promoted immune evasion and therapy resistance by fostering myeloid-enriched but T cell-excluded TMEs with elevated extracellular matrix (ECM). Targeting the ECM-crosslinking enzyme LOXL2 effectively remodeled the metastatic TME, enhancing T cell infiltration and improving therapeutic efficacy in lung metastases across multiple cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 20031, China; University of Chinese Acade…
- Guangzhou National Laboratory, Guangzhou 510005, China.
- Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 20031, China.
- Hepatobiliary Surgery Center, Department of General Surgery, Cancer Metastasis Institute, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
- Guangzhou National Laboratory, Guangzhou 510005, China. Electronic address: jing_naihe@gzlab.ac.cn.
Förderung
- Chinese Academy of Sciences
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Wang, Y., Hu, W., Xia, R., Yang, X., Gu, Y., Ning, Z., Yang, T., Yu, C., Zhang, L., Li, D., Jin, Y., Li, J., Zhang, F., Xu, Y., Xu, C., Wang, Z., Jing, N., Chen, L., & Wang, G. (2026). CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response. Cell, 189(5), 1555-1572.e23. https://doi.org/10.1016/j.cell.2025.12.042
Vancouver
Wang Y, Hu W, Xia R, Yang X, Gu Y, Ning Z, et al. CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response. Cell. 2026;189(5):1555-1572.e23. doi:10.1016/j.cell.2025.12.042
BibTeX
@article{Wang2026,
author = {Wang, Yinghua and Hu, Weiwei and Xia, Rui and Yang, Xianfa and Gu, Yange and Ning, Zihan and Yang, Tiange and Yu, Chune and Zhang, Lulu and Li, Dun and Jin, Yitian and Li, Jianhua and Zhang, Feifei and Xu, Yaochen and Xu, Chenqi and Wang, Zhengxin and Jing, Naihe and Chen, Luonan and Wang, Guangchuan},
title = {CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response},
journal = {Cell},
year = {2026},
volume = {189},
number = {5},
pages = {1555--1572.e23},
doi = {10.1016/j.cell.2025.12.042}
}
EUVIMED